Real-world use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers/β-blocks in Chinese patients before acute myocardial infarction occurs: patient characteristics and hospital follow-up

BACKGROUND: Current guidelines recommend angiotensin-converting-enzyme inhibitors (ACEI) or angiotensin-receptor blockers (ARB) or β-blockers (β-B) for secondary prevention in patients after an acute myocardial infarction (AMI). However, there is limited data to evaluate ACEI/ARB/β-B (AAβ) used befo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Xuhe, Ding, Xiaosong, Chen, Hui, Li, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288924/
https://www.ncbi.nlm.nih.gov/pubmed/30526628
http://dx.doi.org/10.1186/s12967-018-1720-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288924/
https://www.ncbi.nlm.nih.gov/pubmed/30526628
http://dx.doi.org/10.1186/s12967-018-1720-3

Ejemplares similares